Literature DB >> 7737286

Analysis of the fine specificity of rat, mouse and human TAP peptide transporters.

J Neefjes1, E Gottfried, J Roelse, M Grommé, R Obst, G J Hämmerling, F Momburg.   

Abstract

Prior to their association with major histocompatibility complex (MHC) class I molecules, peptides generated from cytosolic antigens need to be translocated by the MHC-encoded peptide transporter (TAP) into the lumen of the endoplasmic reticulum (ER). While class I molecules possess well-known binding characteristics for peptides, the fine specificity of TAP for its peptide substrates has not been analyzed in detail. Previously, we have studied the effect of amino acid variations at the N-terminal, the C-terminal, and the penultimate residue on the efficiency of peptide translocation. Using permeabilized cells, we have shown that TAP pre-selects peptides in an allele- and species-specific manner, for which only the C-terminal residue is crucial. This finding is confirmed in the present study by using microsomes containing different TAP. The influence of amino acid substitutions at positions 2 to 7 of 9-residue model peptides on TAP-dependent peptide translocation is systematically examined. Only a few amino acid substitutions at these positions affect the efficiency of peptide translocation significantly, e.g. Pro at position 2 or 3 negatively influences transport whereas Glu at positions 6 and 7 enhances transport. The differences in translocation by the rat TAP alleles a or u, mouse TAP and human TAP are, however, minor for the peptide with internal substitutions used in this study. These results show that the C-terminal residue essentially governs the species-specific substrate specificity of TAP.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7737286     DOI: 10.1002/eji.1830250444

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  22 in total

1.  Presentation of cytosolic glycosylated peptides by human class I major histocompatibility complex molecules in vivo.

Authors:  J S Haurum; I B Høier; G Arsequell; A Neisig; G Valencia; J Zeuthen; J Neefjes; T Elliott
Journal:  J Exp Med       Date:  1999-07-05       Impact factor: 14.307

2.  Getting peptide vaccines to work: just a matter of quality control?

Authors:  Esteban Celis
Journal:  J Clin Invest       Date:  2002-12       Impact factor: 14.808

3.  Epstein-Barr virus isolates retain their capacity to evade T cell immunity through BNLF2a despite extensive sequence variation.

Authors:  Daniëlle Horst; Scott R Burrows; Derek Gatherer; Bonnie van Wilgenburg; Melissa J Bell; Ingrid G J Boer; Maaike E Ressing; Emmanuel J H J Wiertz
Journal:  J Virol       Date:  2011-10-19       Impact factor: 5.103

4.  Recognition principle of the TAP transporter disclosed by combinatorial peptide libraries.

Authors:  S Uebel; W Kraas; S Kienle; K H Wiesmüller; G Jung; R Tampé
Journal:  Proc Natl Acad Sci U S A       Date:  1997-08-19       Impact factor: 11.205

Review 5.  Variability in immune response to pathogens: using measles vaccine to probe immunogenetic determinants of response.

Authors:  G A Poland
Journal:  Am J Hum Genet       Date:  1998-02       Impact factor: 11.025

Review 6.  Molecular mechanisms of class I major histocompatibility complex antigen processing and presentation.

Authors:  Y Yang; P Sempé; P A Peterson
Journal:  Immunol Res       Date:  1996       Impact factor: 2.829

Review 7.  Peptide selection for presentation by HLA class I: a role for the human transporter associated with antigen processing?

Authors:  P M van Endert
Journal:  Immunol Res       Date:  1996       Impact factor: 2.829

Review 8.  Insights into the processing of MHC class I ligands gained from the study of human tumor epitopes.

Authors:  Nathalie Vigneron; Benoît J Van den Eynde
Journal:  Cell Mol Life Sci       Date:  2011-03-09       Impact factor: 9.261

9.  Analysis and prediction of affinity of TAP binding peptides using cascade SVM.

Authors:  Manoj Bhasin; G P S Raghava
Journal:  Protein Sci       Date:  2004-03       Impact factor: 6.725

10.  Use of Functional Polymorphisms To Elucidate the Peptide Binding Site of TAP Complexes.

Authors:  Jie Geng; Irina D Pogozheva; Henry I Mosberg; Malini Raghavan
Journal:  J Immunol       Date:  2015-08-31       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.